We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.91B
AUM Growth
-$58.7M
Cap. Flow
-$6.54M
Cap. Flow %
-0.34%
Top 10 Hldgs %
39.91%
Holding
252
New
15
Increased
80
Reduced
73
Closed
17

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$5.48M
2
MS icon
Morgan Stanley
MS
+$5.37M
3
PFE icon
Pfizer
PFE
+$4.76M
4
FAST icon
Fastenal
FAST
+$4.66M
5
TGT icon
Target
TGT
+$4.36M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$14.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$11.8M
3
DIS icon
Walt Disney
DIS
+$8.48M
4
LMT icon
Lockheed Martin
LMT
+$6.84M
5
TRV icon
Travelers Companies
TRV
+$3.24M

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.07%
2 Technology 21.25%
3 Healthcare 12.53%
4 Financials 11.18%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMC icon
151
Vulcan Materials
VMC
$36.9B
$827K 0.04%
4,500
– –
ET icon
152
Energy Transfer Partners
ET
$70B
$807K 0.04%
72,120
– –
HIMS icon
153
Hims & Hers Health
HIMS
$7.44B
$799K 0.04%
150,000
– –
EMR icon
154
Emerson Electric
EMR
$89B
$775K 0.04%
7,900
+600
+8% +$56.8K
EW icon
155
Edwards Lifesciences
EW
$51.6B
$766K 0.04%
6,511
– –
FSLR icon
156
First Solar
FSLR
$26.2B
$754K 0.04%
9,000
– –
BP icon
157
BP
BP
$109B
$750K 0.04%
25,500
+1,000
+4% +$30.5K
NVO
158
Novo Nordisk
NVO
$196B
$744K 0.04%
13,400
– –
D icon
159
Dominion Energy
D
$60.9B
$740K 0.04%
8,714
– –
IFF icon
160
International Flavors & Fragrances
IFF
$20.7B
$735K 0.04%
5,600
– –
T icon
161
AT&T
T
$160B
$707K 0.04%
39,588
-9,003
-19% -$167K
F icon
162
Ford
F
$56.8B
$685K 0.04%
40,500
– –
HUM icon
163
Humana
HUM
$43.5B
$664K 0.03%
1,525
– –
CSX icon
164
CSX Corp
CSX
$94.5B
$649K 0.03%
17,320
-67,404
-80% -$2.38M
MU icon
165
Micron Technology
MU
$1.01T
$631K 0.03%
8,100
+1,300
+19% +$111K
DEO icon
166
Diageo
DEO
$48.8B
$630K 0.03%
3,100
+800
+35% +$160K
MKC icon
167
McCormick & Company Non-Voting
MKC
$14B
$599K 0.03%
6,000
– –
KMB icon
168
Kimberly-Clark
KMB
$37B
$597K 0.03%
4,850
-100
-2% -$13.2K
SEE
169
DELISTED
Sealed Air
SEE
$596K 0.03%
8,900
-300
-3% -$20K
APD icon
170
Air Products & Chemicals
APD
$65.6B
$562K 0.03%
2,250
– –
GLW icon
171
Corning
GLW
$137B
$543K 0.03%
14,720
– –
HON icon
172
Honeywell
HON
$78.9B
$524K 0.03%
2,857
– –
ULTA icon
173
Ulta Beauty
ULTA
$23.4B
$518K 0.03%
+1,300
New +$489K
PSX icon
174
Phillips 66
PSX
$82.5B
$510K 0.03%
5,900
-174
-3% -$14.6K
BA icon
175
Boeing
BA
$187B
$507K 0.03%
2,650
-300
-10% -$60.2K
5 6
7
8 9

Similar funds

MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
WGAM
Wilkinson Global Asset Management New York $1.31B AUM 17.03% 1-Year Est. Return

Cullinan Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Cullinan Associates held 252 positions worth $1.91B, down 3% from $1.96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cullinan Associates's Q1 2022 filing shows 15 new, 80 increased, 73 reduced and 17 closed positions. Its largest new stake was West Pharmaceutical: 14,000 shares worth $5.75M. The largest sale was Walmart Inc, an estimated $14.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q1 2022 buy was West Pharmaceutical: 14,000 shares worth $5.75M.
  • Cullinan Associates added most to Morgan Stanley in Q1 2022, an estimated $5.37M increase.
  • Cullinan Associates's biggest Q1 2022 reduction was Walmart Inc, cutting an estimated $14.5M.
  • Cullinan Associates fully exited Vontier in Q1 2022, selling an estimated $758K.
  • Cullinan Associates's ten largest holdings make up 40% of its $1.91B portfolio in Q1 2022.
  • Cullinan Associates opened 15 new positions and closed 17 in Q1 2022.
  • Cullinan Associates's portfolio value fell 3% quarter-over-quarter to $1.91B.

Based on Cullinan Associates's 13F filing for Q1 2022, filed 21 Apr 2022.